This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
WCET 2024
SUPS 2024
BCAN TT 2024
SNMMI 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Conference Highlights
AUA 2017
AUA 2017
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testis & Penile Cancers
BPH
GU Reconstruction
Infections & Inflammation
Sexual Function
Stone Disease - Endourology & Technology
Urinary Incontinence
Press Releases
AUA 2017 Bladder Cancer
Viewing 21-40 of 73 articles
AUA 2017: Race and Finasteride Use: Differential Impact on Bladder Cancer Risk
AUA 2017: Outcomes of Urothelial Bladder Cancer Patients Who Had Previous Upper Tract Urothelial Disease
AUA 2017: Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma
AUA 2017: A Prospective, Multicenter, Randomized Trial of Open Versus Robotic Radical Cystectomy (RAZOR)
AUA 2017: Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-Invasive Urothelial Carcinoma of the Bladder
AUA 2017: Neoadjuvant Chemotherapy for Elderly Patients with Locally Advanced or Early Nodal Disease: Are We Doing Enough?
AUA 2017: Safety and Efficacy Gemcitabine-Cisplatin Split Dose as a Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
AUA 2017: Distribution of Lymph Node Metastasis in Upper Urinary Tract Urothelial Cancer, Sub-Analysis of JCOG1110A Study
AUA 2017: Efficacy of Chemotherapy Administration in Elderly Patients with Metastatic Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy
AUA 2017: Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma
AUA 2017: Bladder Cancer Tumor Board
AUA 2017: E-Cigarette Smoke is potentially Bladder Carcinogenic- It Induces Tumorigenic DNA Adducts and Inhibits DNA Repair in Urothelial Cells
AUA 2017: State-of-the-Art Lecture: Immunotherapy for Bladder Cancer
AUA 2017: Clinical Destiny of Indeterminate Pulmonary Nodules in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder
AUA 2017: Use of Adjuvant Chemotherapy In Patients With Advanced Bladder Cancer After Neoadjuvant Chemotherapy
AUA 2017: Dose Dense Mvac Prior To Radical Cystectomy: A Retrospective Multi-institutional Experience
AUA 2017: Genomic Differences Between “Primary” And “Secondary” Muscle Invasive Bladder Cancer: Implications For Neoadjuvant Chemotherapy
AUA 2017: Incompleteness Of The Transurethral Resection As A Predictor Of Adverse Pathological Features At The Time Of Radical Cystectomy: Implications For Neoadjuvant Chemotherapy Selection
AUA 2017: Panel Discussion - Clinical Bladder Cancer Quandaries: What to Do Today and in the Future?
AUA 2017:Non-Muscle Invasive Bladder Cancer Guidelines
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free